BRIEF published on 04/05/2024 at 22:05, 1 year 11 months ago Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
BRIEF published on 04/05/2024 at 22:05, 1 year 11 months ago Abivax annonce la soumission de rapports financiers aux agences de régulation françaises et américaines Abivax Maladies Inflammatoires Chroniques Rapports Financiers Les Organismes De Réglementation Annonce De Diffusion Web
PRESS RELEASE published on 04/05/2024 at 22:00, 1 year 11 months ago Abivax a déposé ses rapports financiers auprès des autorités de marchés financiers française et américaine Abivax dépose ses rapports financiers auprès des autorités de marchés français et américaine, annonçant la disponibilité de ses documents pour l'année 2023 Biotechnologie Abivax Investisseurs Rapports Financiers Autorités De Marchés
PRESS RELEASE published on 04/05/2024 at 22:00, 1 year 11 months ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF published on 04/02/2024 at 08:35, 1 year 11 months ago Abivax Reports 2023 Financial Results and Operational Update Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
BRIEF published on 04/02/2024 at 08:35, 1 year 11 months ago Abivax publie ses résultats financiers 2023 et un point opérationnel Résultats Financiers Abivax Obefazimod Rectocolite Hémorragique Introduction En Bourse Au Nasdaq
PRESS RELEASE published on 04/02/2024 at 08:30, 1 year 11 months ago Abivax reports 2023 financial results and operational update Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024 Financial Results Fundraising Abivax Webcast Operational Update
PRESS RELEASE published on 04/02/2024 at 08:30, 1 year 11 months ago Abivax publie ses résultats annuels 2023 et présente un point d’avancement sur l’activité Abivax publie ses résultats annuels 2023 et présente un point d'avancement sur l'activité, démontrant une forte croissance financière et des progrès dans ses programmes cliniques Croissance Financement Abivax Résultats Annuels 2023 Programmes Cliniques
BRIEF published on 03/27/2024 at 18:05, 1 year 11 months ago ABIVAX publie son nombre d’actions et de droits de vote au 29 février 2024 Euronext Paris Droits De Vote Capital Social Abivax Réglementation
BRIEF published on 03/27/2024 at 18:05, 1 year 11 months ago ABIVAX publishes its number of shares and voting rights as of February 29, 2024 Euronext Paris Share Capital Voting Rights Abivax Regulation
Published on 03/23/2026 at 14:05, 32 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 37 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 1 hour 32 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 2 hours 5 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 2 hours 7 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 14:24, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 14:18, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 03/23/2026 at 08:10, 6 hours 27 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 19 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 19 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
